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Introduction 
The concept of sampling newborn infants for a few microliters of blood to screen for inherited endocrine, nutritional, 
or metabolic disorders has been introduced by Guthrie at the University of Buffalo in 19631. Newborn screening for 
additional diseases has since been extensively performed in North America and Europe (Newborn Screening 
Programs - NSPs), but also in developing countries because of the ease of collection, transport, and storage, as well 
as the reduced risk of contamination of the handlers due to infectious pathogens, compared to the use of classical 
liquid specimens. Human dried-blood spots (DBS) are generally simply obtained by pricking the heel or finger by 
using single-use lancing devices to sample a few microliters (50-150 µl) of capillary blood. The blood is then 
collected on a piece of filter paper made of high purity cotton linters2. After drying, DBS are stored in plastic bags at 
ambient temperature. For analysis, part of the spot is punched out (6 mm punches) and the blood is eluted using 
various aqueous solutions3. In recent years, DBS testing further evolved towards more extensive testing due to the 
availability of more sensitive and specific methodologies. Next to screening for congenital diseases and viruses, DBS 
from NSPs have thus lately also been considered for exposure to toxicant assessment. To the best of our knowledge, 
only Dua et al. and Burse et al. briefly reported preliminary data on the potential use of DBS for 
hexachlorocyclohexane (HCH), dichlorodiphenyltrichloroethane (DDT), and dichlorodiphenyldichloroethylene 
(DDE) measurement using GC coupled to non-selective micro-electron capture detector (µECD)4,5. 
 
The aim of the work is to develop new analytical strategies to measure selected representative POPs (or metabolites 
or reaction products) in DBS to assess internal dose exposure by means of innovative minimally-invasive 
biomonitoring. The methodology is be based on cryogenic modulation of gas chromatographic signals, either applied 
to comprehensive two-dimensional gas chromatography (GCxGC), or to cryogenic zone compression (CZC)-GC. 
Both GC approaches to be hyphenated to high resolution (HR) mass spectrometric (MS) analyzers. 
 
Materials and Methods 
Chemicals 
All chemicals and instrumentation are similar to those used for dioxin routine analyses under ISO17025 QA/QC 
requirements. A human serum QC pool was used for optimization and testing. This pool is naturally contaminated 
and is representative of the general European population background levels. The target analytes consisted in DDE, 
PCB-153. They can be considered as indicator of PCB and organochlorine pesticide (OCP) levels. 
 
Analytical procedure 
For method development, sample sizes ranged between 200 µL and 1 mL. Each sample was liquid-liquid extracted 
using hexane. Briefly, samples were placed in 10 mL conical bottom polypropylene FalconTM tubes. The extraction 
was carried out with three times 5 mL of hexane and wrist-action shaking. The solvent extract was evaporated in a 
PowerVap 6 system (Fluid Management Systems Inc., Waltham, MA, USA) to 500 µL using regular evaporation 
tubes. This volume was loaded on a multilayer micro column made of 0.4g of sodium sulphate and 0.5g of 22% 
sulphuric acid silicagel, from top to bottom. The eluate (3 x 2 mL of hexane) was concentrated to 400 µL in the 
PowerVap using GC-vial connected evaporation tubes. Final solvent reduction took place overnight at room 
temperature after 5 µL of nonane was added as keeper. The final extract volume was 5 µL. 
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Measurements were carried out on a JEOL AccuTOF GC system (JEOL Ltd., Tokyo, Japan). The GC oven (Agilent 
6890) was equipped with a ZX1 - LN2 Cooled Loop Modulation GC x GC System (Zoex Corp., Houston, TX, USA). 
The 1D GC column was an HT-8 (60 m x 0.25 mm ID x 0.25 µm df) (SGE, Villebon, France). The 2D GC column 
was an Rxi-17 (1.5 m x 0.25 mm ID x 0.25 µm df) (Restek, , Belletonte, PA, USA). The PM was 4 s, 400 ms of hot 
pulse duration. The temperature program was 140°C for 2 min, 15°C/min to 220°C for 7,5 min, 6°C/min to 250°C, 
2°C/min to 265°C, 30°C/min to 310°C for 20 min. 1 µL of the final extract in nonane (5 µL) were injected into a 
split/splitless injector held at 275°C in splitless mode. Helium was used at 0.8 mL/min. The major MS parameters 
were an ion source temperature of 140°C, an ionisation voltage of 200 V, methane at 1 mL/min as reagent gas, an 
acquisition range from 30.00 to 700.00 m/z, a recording interval of 0.04 s (25 Hz), an accumulation time of 0.037 s, a 
data sampling interval of 0.5 ns, and a detector voltage of 2300 V. The mass accuracy of the instrument was ensured 
by frequent single point calibration checks. 
 
Results and Discussion 
Cryogenic zone compression (CZC) 
CZC was performed to enhance instrumental LODs. The iLODs for PCB-153 were 50 fg/µL, and iLODs for DDE 
were 5 pg/ µL. We tried to incorporate BDE-47 in the set of analytes but the iLODs were not good enough. We used 
a 60m carborane GC phase to ensure proper separation of PCBs and avoid co-elution of targets with other isobaric 
species. The width at half height was 150 ms. This corresponded to several slices per peak, excepted for the lowest 
points of the calibration curve where only one slice was often observed. The calibration curve working zone ranged 
from 50 fg to 100 pg for PCB-153 and from 1 pg to 500 pg for DDE. Curves are illustrated in Figure 1. PCB-153 
13C-labeleld standard was used to quantify both PCB-153 and DDE because 13C DDE was not available at the time of 
experiments. This is the reason for the surprising response factor for DDE curve. 
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Analyses of real human serum samples 
Quality control human serum samples (500 µL) were analyzed to estimate the efficiency of the procedure. Triplicate 
analyses gave a mean level of 0.85 ± 0.26 pg/g lipids (29% RSD) although the reference value for that QC pool was 
0.90 pg/g lipids (-4.6% relative error) for PCB-153.  
 
Real human serum samples were also analyzed. They consisted in 500 µL specimen volumes. The internal standard 
was added prior extraction. Figure 2 shows the actual chromatograms for both PCB-153 and DDE naturally present 
in the sample. Both were quantified. 
 
Figure 2: Signals for native PCB-153 and DDE in 500 µL of human blood analyzed by GCxGC-IDHRTOFMS. 
 
Relative errors were around 20% or higher, especially for DDE for which measurements were performed at levels 
very close to iLODs. Investigation of the relatively poor accuracy revealed serious variations in the sample 
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preparation  itself, in terms of recovery rates. Optimisation of the entire sample workflow is under consideration. No 
doubt that the use of 13C DDE should improve the performance of the method. In terms of blank levels, no issues 
were encountered for DDE, but blank levels for PCB-153 were of concern and efforts should be considered to ensure 
proper control of contamination.  
 
Conclusions 
Those preliminary results demonstrate the feasibility of such a DBS approach for measuring selected POPs in human 
samples. The work performed on liquid serum samples of 500 µL has to be extended to actual whole blood BDS to 
further investigate the efficiency of the method. HR sector instrument also have to be used to take advantage of the 
sensitivity enhancement while working in selected ion monitoring (SIM) mode. Research is currently taking place in 
that field (see OHC this year). 
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